ADXN's free cash flow for Q4 2022 was CHF―. For the 2022 fiscal year, ADXN's free cash flow was decreased by CHF-1.70M and operating cash flow was CHF―. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Operating Cash Flow	CHF -13.37M	CHF -16.44M	CHF -14.71M	CHF -12.18M	CHF -9.48M	CHF 1.75M
Investing Cash Flow	CHF 2.98K	CHF 2.97K	CHF -30.31K	CHF -59.41K	CHF -43.25K	CHF -56.37K
Financing Cash Flow	CHF 3.27M	CHF 3.10M	CHF 16.40M	CHF 46.40K	CHF -463.69K	CHF 37.39M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	CHF 34.12M	CHF 7.15M	CHF 20.36M	CHF 18.70M	CHF 31.54M	CHF 41.67M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	CHF 1.68M	-	CHF 10.16M	CHF 720.01K	CHF 5.99K	CHF 40.49M
Issuance Of Debt	-	CHF -288.08K	CHF -309.62K	-	-	-
Repayment Of Debt	CHF -221.10K	CHF -288.08K	CHF -309.62K	CHF -367.41K	CHF -316.79K	CHF 0.00
Free Cash Flow	CHF -13.37M	CHF -16.44M	CHF -14.74M	CHF -12.24M	CHF -9.51M	CHF 1.74M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in CHF

Addex Therapeutics Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing